Arrowhead Pharmaceuticals Acquires FDA Priority Review Voucher
Go back to Arrowhead Pharmaceuticals Acquires FDA Priority Review Voucher| ARROWHEAD RESEARCH (NASDAQ: ARWR) | Delayed: 87.89 -1.7 (1.9%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $89.59 | 52 Week High | $8.22 | |||
| Open | $87.49 | 52 Week Low | $3.07 | |||
| Day High | $90.81 | P/E | N/A | |||
| Day Low | $85.98 | EPS | $-1.30 | |||
| Volume | 940,997 | |||||
